MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 224 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,961,995
+14.7%
108,717
-6.3%
0.04%
+27.6%
Q2 2023$2,582,869
-5.1%
116,084
-7.6%
0.03%
-9.4%
Q1 2023$2,722,012
+17.8%
125,670
+10.5%
0.03%
+10.3%
Q4 2022$2,310,405
-19.1%
113,757
+2.1%
0.03%
-25.6%
Q3 2022$2,856,000
+647.6%
111,387
+593.6%
0.04%
+680.0%
Q2 2022$382,000
+23.6%
16,060
+16.9%
0.01%
+66.7%
Q1 2022$309,000
+20.2%
13,738
+6.0%
0.00%0.0%
Q4 2021$257,000
-6.2%
12,955
-6.9%
0.00%0.0%
Q3 2021$274,000
-16.5%
13,913
-6.8%
0.00%0.0%
Q2 2021$328,000
-2.1%
14,923
+5.8%
0.00%
-25.0%
Q1 2021$335,000
-1.8%
14,100
+8.0%
0.00%0.0%
Q4 2020$341,000
+57.1%
13,053
+4.6%
0.00%
+33.3%
Q3 2020$217,000
+155.3%
12,483
+147.4%
0.00%
+200.0%
Q2 2020$85,000
+57.4%
5,045
+11.1%
0.00%0.0%
Q1 2020$54,000
+20.0%
4,539
+22.7%
0.00%0.0%
Q4 2019$45,000
-16.7%
3,700
-2.3%
0.00%0.0%
Q3 2019$54,000
+28.6%
3,786
+0.8%
0.00%0.0%
Q2 2019$42,000
+20.0%
3,757
+26.1%
0.00%0.0%
Q1 2019$35,0000.0%2,980
+12.9%
0.00%0.0%
Q4 2018$35,000
+25.0%
2,639
+31.5%
0.00%
Q3 2018$28,000
+366.7%
2,007
+471.8%
0.00%
Q2 2018$6,0003510.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders